covid 19 News and Research

RSS

COVID-19 lockdowns have stunted the development of schoolchildren

This month the few remaining countries in East Asia and the Pacific that had kept schools shuttered since the COVID-19 outbreak are reopening, some on a limited scale.

1 Oct 2021

Comparison of Pfizer, Moderna, J&J, AZ vaccines for neutralization titer, against Delta and other variants

Is one COVID vaccine better than the other? Four current vaccines — Moderna, Pfizer-BioNTech, Johnson & Johnson, and AstraZeneca — are highly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but a new medRxiv* study suggests the level of protection varies.

30 Sep 2021

New approach reveals ‘protein partners’ that may contribute to unusual pathologies of COVID-19

COVID-19 not only causes symptoms characteristic of a typical respiratory disorder, but has also been known to trigger a wide range of other symptoms in people who had been infected, some lasting even long after individuals test negative for the virus.

30 Sep 2021

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase III Coronavirus Efficacy (COVE) clinical trial find the Moderna vaccine reduces severe acute respiratory coronavirus 2 (SARS-CoV-2) viral load and viral shedding.

30 Sep 2021

Non-severe COVID-19 may elicit more durable memory B cell response than severe COVID-19

A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.

30 Sep 2021

University of Oxford and Oracle's Global Pathogen Analysis System helping researchers to combat COVID-19

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle's Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.

30 Sep 2021

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

30 Sep 2021

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

A team of scientists from the USA and France has recently unveiled the mechanism of immune dysregulation in coronavirus disease 2019 (COVID-19) patients by analyzing the early-stage interaction between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected epithelial cells and immune cells. The study is currently available on the bioRxiv* preprint server.

30 Sep 2021

Immigration adds 1.4 to 1.5 years to U.S. life expectancy, study says

If immigrants to the United States formed their own country, their pre-COVID-19 life expectancies would exceed or match those of the world's leaders in longevity -; Swiss men and Japanese women.

30 Sep 2021

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.

30 Sep 2021

Rise of the Delta variant increases COVID-19 hospitalizations among unvaccinated pregnant women

Unvaccinated pregnant women are increasingly being hospitalized with COVID-19 during a nationwide surge of the Delta variant, according to research from UT Southwestern Medical Center.

30 Sep 2021

The connection between age and virulence of SARS-CoV-2 variants of concern

A new study focuses on determining the existence of an age-related heterogeneity in the severity of COVID-19.

30 Sep 2021

Government sets additional funding for infection prevention and control in social care settings

People who receive care and the adult social care workforce will be further protected from COVID-19 and flu over the coming months, as the government sets additional funding for infection prevention and control.

30 Sep 2021

40 new one-stop-shops for checks, scans and tests set to open across England

Millions of patients will benefit from earlier diagnostic tests closer to home thanks to 40 new Community Diagnostic Centres set to open across England in a range of settings from local shopping centers to football stadiums.

30 Sep 2021

Covid is killing rural Americans at twice the rate of urbanites

Rural Americans are dying of covid at more than twice the rate of their urban counterparts — a divide that health experts say is likely to widen as access to medical care shrinks for a population that tends to be older, sicker, heavier, poorer and less vaccinated.

30 Sep 2021

A covid test costing more than a Tesla? It happened in Texas.

When covid-19 struck last year, Travis Warner's company became busier than ever. He installs internet and video systems, and with people suddenly working from home, service calls surged.

30 Sep 2021

SARS-CoV-2 nucleocapsid antigen as a possible COVID-19 severity marker

French researchers used a highly sensitive and specific nucleocapsid-Ag assay to explore the relationship between N-Ag in urine during COVID-19 and the severity of the disease in hospitalized patients.

30 Sep 2021

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

This new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.

30 Sep 2021

New drug combination effectively suppresses SARS-CoV-2 infection

More countries with greater resources are opening up for a more normal life. But COVID-19 and the SARS-CoV-2 virus are still a significant threat in large parts of the world.

30 Sep 2021

The applications of nanomaterials against viral disease

The application of nanomaterials in the diagnosis, prevention, and treatment of viral diseases is reviewed in detail, highlighting areas of significant progress or stagnation from the past few decades.

30 Sep 2021

covid 19 News and Research

COVID-19 lockdowns have stunted the development of schoolchildren

Comparison of Pfizer, Moderna, J&J, AZ vaccines for neutralization titer, against Delta and other variants

New approach reveals ‘protein partners’ that may contribute to unusual pathologies of COVID-19

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

Non-severe COVID-19 may elicit more durable memory B cell response than severe COVID-19

University of Oxford and Oracle's Global Pathogen Analysis System helping researchers to combat COVID-19

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

Immigration adds 1.4 to 1.5 years to U.S. life expectancy, study says

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

Rise of the Delta variant increases COVID-19 hospitalizations among unvaccinated pregnant women

The connection between age and virulence of SARS-CoV-2 variants of concern

Government sets additional funding for infection prevention and control in social care settings

40 new one-stop-shops for checks, scans and tests set to open across England

Covid is killing rural Americans at twice the rate of urbanites

A covid test costing more than a Tesla? It happened in Texas.

SARS-CoV-2 nucleocapsid antigen as a possible COVID-19 severity marker

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

New drug combination effectively suppresses SARS-CoV-2 infection

The applications of nanomaterials against viral disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News